Skip to content
10-Q

Quarterly Report

Zentalis Pharmaceuticals, Inc. ZNTL

0001725160-25-000161

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 1, 2025 72.25M sh
Shares Diluted Q3 2025 · Sep 30, 2025 72.14M sh
Shares Diluted Q3 2025 · Sep 30, 2025 71.94M sh
Shares Diluted Q3 2025 · Sep 30, 2024 71.11M sh
Shares Diluted Q3 2025 · Sep 30, 2024 71.02M sh
Capex Q3 2025 · Sep 30, 2025 $0
Capex Q3 2025 · Sep 30, 2024 $221K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$94.31M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$131.16M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $39.07M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $33.9M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $41.32M
Stockholders Equity Q3 2025 · Sep 30, 2025 $252.87M
Stockholders Equity Q3 2025 · Dec 31, 2024 $337.19M
Current Liabilities Q3 2025 · Sep 30, 2025 $37.17M
Current Liabilities Q3 2025 · Dec 31, 2024 $52.73M
Total Liabilities Q3 2025 · Sep 30, 2025 $74.38M
Total Liabilities Q3 2025 · Dec 31, 2024 $93.15M
Current Assets Q3 2025 · Sep 30, 2025 $288.3M
Current Assets Q3 2025 · Dec 31, 2024 $386.07M
Total Assets Q3 2025 · Sep 30, 2025 $327.25M
Total Assets Q3 2025 · Dec 31, 2024 $430.34M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.37
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.42
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.56
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.67
Eps Basic Q3 2025 · Sep 30, 2025 −$0.37
Eps Basic Q3 2025 · Sep 30, 2025 −$1.42
Eps Basic Q3 2025 · Sep 30, 2024 −$0.56
Eps Basic Q3 2025 · Sep 30, 2024 −$1.67
Sga Expense Q3 2025 · Sep 30, 2025 $10.78M
Sga Expense Q3 2025 · Sep 30, 2025 $29.81M
Sga Expense Q3 2025 · Sep 30, 2024 $14.61M
Sga Expense Q3 2025 · Sep 30, 2024 $47.11M
Rd Expense Q3 2025 · Sep 30, 2025 $22.95M
Rd Expense Q3 2025 · Sep 30, 2025 $77.81M
Rd Expense Q3 2025 · Sep 30, 2024 $36.82M
Rd Expense Q3 2025 · Sep 30, 2024 $134.8M
Net Income Q3 2025 · Sep 30, 2025 −$26.69M
Net Income Q3 2025 · Sep 30, 2025 −$101.84M
Net Income Q3 2025 · Sep 30, 2024 −$40.16M
Net Income Q3 2025 · Sep 30, 2024 −$118.37M
Operating Income Q3 2025 · Sep 30, 2025 −$33.73M
Operating Income Q3 2025 · Sep 30, 2025 −$115.42M
Operating Income Q3 2025 · Sep 30, 2024 −$51.43M
Operating Income Q3 2025 · Sep 30, 2024 −$141.35M
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2024 $0
Revenue Q3 2025 · Sep 30, 2024 $40.56M